title: Severe malaria and artesunate treatment, Norway.
authors.forename: Kristine
authors.initials: K
authors.lastname: Mørch
authors.forename: Øystein
authors.initials: Ø
authors.lastname: Strand
authors.forename: Oona
authors.initials: O
authors.lastname: Dunlop
authors.forename: Ase
authors.initials: A
authors.lastname: Berg
authors.forename: Nina
authors.initials: N
authors.lastname: Langeland
authors.forename: Rafael A M
authors.initials: RA
authors.lastname: Leiva
authors.forename: Jørn-Age
authors.initials: JA
authors.lastname: Longva
authors.forename: Håkon
authors.initials: H
authors.lastname: Sjursen
authors.forename: Steinar
authors.initials: S
authors.lastname: Skrede
authors.forename: Jon
authors.initials: J
authors.lastname: Sundal
authors.forename: Mogens
authors.initials: M
authors.lastname: Jensenius
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000962:Antimalarials / Q000008:administration & dosage / Q000627:therapeutic use*; D037621:Artemisinins / Q000008:administration & dosage / Q000627:therapeutic use*; D000077332:Artesunate; D002981:Clindamycin / Q000008:administration & dosage / Q000627:therapeutic use; D004318:Doxycycline / Q000008:administration & dosage / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D007275:Injections, Intravenous; D016778:Malaria, Falciparum / Q000188:drug therapy*; D008499:Medical Records; D008875:Middle Aged; D009664:Norway; D011500:Protein Synthesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D000962:Antimalarials; D037621:Artemisinins; D011500:Protein Synthesis Inhibitors; D002981:Clindamycin; D000077332:Artesunate; D004318:Doxycycline